| Ytd | 14.30% | |
| 1y | 14.94% |
| Open | 27.85 | Prev Close | 27.96 | Low | 27.64 | High | 28.70 | Mkt Cap | 162.21B |
| Vol | 45.44M | Avg Vol | 42.22M | EPS | 0.77 | P/E | 36.96 | Forward P/E | 9.83 |
| Beta | 0.28 | Short Ratio | 3.69 | Inst. Own | 69.15% | Dividend | 1.72 | Div Yield | 6.15 |
| Ex Div Date | 07-24 | Earning | 11-03 | 50-d Avg | 25.64 | 200-d Avg | 26.10 | 1yr Est | 28.61 |
Nearly a dozen drugmakers are reportedly slated to voluntarily sell their medications at lower price
PFE's oncology growth is led by Padcev, while a broad pipeline and label expansions aim to fuel long
On CNBC's “Halftime Report Final Trades,” Kevin Simpson, founder and CEO of Capital Wealth Planning,
Take-Two Interactive Software, on Aug. 7, reported adjusted earnings were 35 cents per share, toppin
Archer Investment Corp bought a new position in shares of Pfizer Inc. (NYSE: PFE) during the second
A single trial readout is reshuffling the mRNA vaccine trade this morning. BioNTech SE (NASDAQ:BNTX
FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligi
The U.S. Food and Drug Administration approved Moderna, Novavax-Sanofi and Pfizer-BioNTech's update
2026-2027 COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closel
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasda
2026-2027 COVID-19 vaccine formula targets the XFG variant, in line with FDA guidance to more closel
Wall Street has spent the last several years discounting a handful of famous dividend names on fears
Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing
Pfizer's management is standing behind the company's dividend. Although earnings aren't covering the
Algert Global LLC raised its holdings in shares of Pfizer Inc. (NYSE: PFE) by 824.1% in the second q
PFE and BMY both boast strong oncology portfolios, but Pfizer's valuation and broader diversificatio
These healthcare leaders are unlikely to suspend their dividend programs.
Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector.
Bank of Nova Scotia lessened its holdings in Pfizer Inc. (NYSE: PFE) by 13.4% during the undefined q
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Our 24/7 Wall St. price target for Pfizer (NYSE:PFE | PFE Price Prediction) points to $32.36 over th
Advisors Capital Management LLC raised its holdings in shares of Pfizer Inc. (NYSE: PFE) by 2.8% in
Danske Bank A S boosted its position in Pfizer Inc. (NYSE: PFE) by 9.2% during the second quarter, a
Danske Bank A S boosted its position in Pfizer Inc. (NYSE: PFE) by 9.2% during the second quarter, a
Edmond DE Rothschild Holding S.A. reduced its position in Pfizer Inc. (NYSE: PFE) by 8.1% in the und
Four Barron's Better Bets (PFE, VZ, RF, KMI) currently offer 'safer' dividends with yields from $1K
Arbutus Biopharma (ABUS) stock rises after announcing a $230M stock buyback via a modified Dutch auc
Merck & Moderna's partnership reports first Phase 3 success for personalized cancer vaccine,
Healthcare stocks saw mixed after-hours moves, with Moderna and Merck cooling after explosive gains
Pfizer Inc (NYSE:PFE) shares are trading higher Wednesday, moving in sympathy with mRNA cancer vacci
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Valneva (VALN) stock surges after EMA validates MAA for Lyme disease vaccine candidate developed wit
A August filing shows that Representative Carol Miller reported a sale in Pfizer (NYSE:PFE), valued
Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results
China’s science surge is reshaping global drug development as Washington moves to counter Beijing’s
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
https://youtu.be/H_RititNE8U
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Guggenheim analyst Vamil Divan maintains Pfizer (NYSE:PFE) with a Buy and lowers the price target
Kathy Hochul says Trump's Medicare subsidy decision will raise prescription drug costs for 1.3 m
Market sentiment improves, Dow Jones jumps 900 points to record high. Crude oil prices fall on poten
Pfizer stock rises after beating Q2 estimates and raising its 2026 revenue guidance to up to $62.5B.
Dow rises 1.35% with technology sector leading market gains. Pfizer beats Q2 earnings expectations.
U.S. stock futures edged higher on Tuesday, with Dow, S&P 500 and Nasdaq 100 futures advancing a
Pfizer (NYSE:PFE) reported quarterly earnings of $0.77 per share which beat the analyst consensus es
Pfizer (NYSE:PFE) affirms FY2026 Adj EPS guidance from $2.80-$3.00 to $2.80-$3.00 vs $2.95 analyst e
Fear & Greed Index improves, Dow Jones hits record high, oil prices fall after Trump's Iran
Stocks to watch today: Caterpillar, Palantir, McDonald's, Snap, Pfizer. Positive Q2 earnings rep
Pfizer (PFE) will release Q2 earnings on Aug. 4, expected to report lower EPS of 68 cents and revenu
Earnings set for tight window on Tuesday, Benzinga Pro data show options pricing 3.19% move for Pfiz